WaveMan · Form 4
Gold Mitchell insider trades
> Search tickers & screens ⌘K
LIVE

Gold Mitchell insider trades

Gold Mitchell has filed 12 Form 4s with the SEC that we hold, for ALPN (Executive Chairman and CEO, Director) and Attovia Therapeutics, Inc. (ATTO) (Director). Across all of them we count 0 purchases worth $0 and 13 sales worth $8.3M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 400,000 shares of ALPN worth $3.8M, dated 2021-09-17. The first filing on our record is dated 2021-09-17 and the latest 2026-08-06.

ALPN

Executive Chairman and CEO, Director · 11 filings · 13 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-09-15S, sale reported on Form 43,484$34.8K2021-09-17
2021-09-16S, sale reported on Form 46,768$67.7K2021-09-17
2021-09-17S, sale reported on Form 4400,000$3.8M2021-09-21
2021-09-17S, sale reported on Form 445,262$453.1K2021-09-21
2023-12-08S, sale reported on Form 48,067$137.8K2023-12-12
2023-12-11S, sale reported on Form 468,870$1.2M2023-12-12
2023-12-12S, sale reported on Form 432,450$562.0K2023-12-12
2023-12-12S, sale reported on Form 48,613$149.2K2023-12-12
2023-12-19S, sale reported on Form 42,402$48.1K2023-12-21
2023-12-22S, sale reported on Form 437,825$772.8K2023-12-27
2023-12-26S, sale reported on Form 424,486$495.1K2023-12-27
2023-12-27S, sale reported on Form 429,573$592.6K2023-12-27
2023-12-28S, sale reported on Form 41,016$20.4K2023-12-29

Attovia Therapeutics, Inc. (ATTO)

Director · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1242882) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms